HPLC determination of acyclovir and zidovudine in maternal plasma, amniotic fluid, fetal, and placental tissues using ultra-violet detection

Journal of Liquid Chromatography and Related Technologies

Volumn 25, Issue 18, 2002, Pages 2857-2871

  Brown, Stacy D ^a   White, Catherine A ^a   Bartlett, Michael G ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Acyclovir; HPLC; Pregnancy; Zidovudine

Indexed keywords

BODY FLUIDS; FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHANOL; PRECIPITATION (CHEMICAL); PROTEINS; TISSUE; ULTRAVIOLET RADIATION; VIRUSES;

ULTRAVIOLET DETECTION;

DRUG PRODUCTS;

ACICLOVIR; DIDANOSINE; LAMIVUDINE; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG TISSUE LEVEL; FEMALE; FETUS; FILTRATION; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOGENATE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PH; PLACENTA; PRECIPITATION; QUANTITATIVE ANALYSIS; RAT; REPRODUCIBILITY; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION; VIRUS TRANSMISSION;

ANIMALIA; HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES; SIMPLEXVIRUS; VIOLA (ANGIOSPERM);

EID: 0036405166     PISSN: 10826076     EISSN: None     Source Type: Journal    
DOI: 10.1081/JLC-120014955     Document Type: Article

References (37)

1. Flemming, D.; McQuillan, G.; Johnson, R. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 1997, 337, 1105-1111.
2. Prober, C.G.; Corey, L.; Brown, Z.A. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin. Infect. Dis. 1992, 15, 1031-1038.
3. Whitley, R.J.; Arvin, A.M.; Prober, C.G. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. N. Engl. J. Med. 1991, 324, 444-449.
4. Whitley, R.J.; Corey, L.; Arvin, A.M. Changing presentation of herpes simplex virus in neonates. J. Infect. Dis. 1988, 158, 109-116.
5. Brenner, B.G.; Wainberg, M.A. Prevention and treatment of HIV infection in infants and children. Ann. of New York Acad. of Sci. 2000, 918, 9-15.
6. Douglas, R.G. Antiviral agents. In Goodman and Gilmans The Pharmacological Basis of Therapeutics, 8th Ed.; Gilman, A.G., Rall, T.W., Nies, A.S., Taylor, P., Eds.; McGraw-Hill: New York, 1982; 1182-1186.
7. Mitsuya, H.; Border, S. Strategies for antiviral therapy in AIDS. Nature 1987, 325, 773-778.
8. Surbone, A.; Yarchoan, R.; McAtee, N.; Blum, M.R.; Maha, M.; Allain, J.P.; Thomas, R.V.; Mitsuya, H.; Lehrman, S.N.; Leuther, M.; Pluda, J.M.; Jacobson, F.K.; Kessler, H.A.; Myers, C.E.; Border, S. Treatment of the Acquired Immunodeficiency Syndrome (AIDS) and AIDS-related complex with a regimen of 3′-azido-2′-3′-dideoxythymidine (azidothymidine or zidovudine) and acyclovir. Ann. Intern. Med. 1988, 108, 534-540.
9. Cooper, D.A.; Pedersen, C.; Aiuti, E; Vilde, J.L.; Ruhnke, M.; Pehrson, P.O.; Clumcek, N.; Farthing, C.; Luthy, R.; Doherty, R.R.; Cload, P.A. The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. AIDS. 1991, 5 (8), 933-943.
10. Bach, M.C. Possible drug interaction during therapy with azidothymidine and acyclovir for AIDS. N. Engl. J. Med. 1987, 316 (9), 547.
11. Mamede, J.A.; Simoes, M.J.; Novo, N.F.; Juliano, Y.; Oliveira-Filho, R.M.; Kulay, L. Chronic effects of azidothymidine and ayclcovir on pregnant rats. Gen. Pharmcol. 1995, 26 (3), 532-526.
12. Greene, J.A.; Ayers, K.M.; de Miranda, P.; Tucker, W.E. Postnatal survival in wistar rats following oral dosage with zidovudine on gestation day 10. Fund. Appl. Tox. 1990, 15, 201-206.
13. Brown, S.D.; White, C.A.; Chu, C.K.; Bartlett, M.G. Determination of Acyclovir in Maternal Plasma, Amniotic Fluid, Fetal and Placental Tissues by High Performance Liquid Chromatography. J. Chrom. B 2002, 772 (2), 327-334.
14. Land, G.; Bye, A. Simple high-performance liquid chromatographic method for the analysis of 9-(2-hydroxyethoxymethyl)guanine (acyclovir) in human plasma and urine. J. Chrom. 1981, 224, 51-58.
15. Swart, K.L.; Hundt, H.K.L.; Groenewald, A.M. Automated high-performance liquid chromatographic method for the determination of acyclovir in plasma. J. Chrom. A 1994, 663, 65-69.
16. Molikhia, A.M.; Niazy, E.M.; El-Hoofy, S.A.; El-Dardari, M.E. Improved liquid chromatographic method for acyclovir determination in plasma. J. Liq. Chrom. 1990, 13 (5), 981-989.
17. Nebinger, P.; Koel, M. Determination of acyclovir by ultrafiltration and high performance liquid chromatography. J. Chrom. B. 1993, 619, 342-344.
18. Cronqvist, J.; Nilsson, I. Determination of acyclovir in human serum by high-performance liquid chromatography. J. Liq. Chrom. 1988, 11 (12), 2593-2601.
19. Pham-Huy, C.; Stathoulopoulou, F.; Sandouk, P.; Scherrmann, J.M.; Palombo, S.; Girre, C. Rapid determination of valacyclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution. J. Chrom. B. 1999, 732, 47-53.
20. Smith, R.L.; Walker, D.D. High-performance liquid chromatographic determination of acyclovir in serum. J. Chrom. B. 1985, 343, 203-207.
21. Svensson, J.O.; Barkholt, L.; Sawe, J. Determination of acyclovir and its metabolite 9-carboxymethoxymethylguanine in serum and urine using solid-phase extraction and high-performance liquid chromatography. J. Chrom. B. 1997, 690, 363-366.
22. Krasny, H.C.; Petty, B.G. Metabolism of desciclovir, a prodrug of acyclovir in humans after multiple oral dosing. J. Clin. Pharmacol. 1987, 27 (1), 74-77.
23. Smidovnik, A.; Wondra, A.G.; Prosek, M. Determination of acyclovir in plasma by high performance liquid chromatography with UV detection. J. High Resol. Chromatogr. 1997, 20, 503-506.
24. Poirier, J.M.; Radembino, N.; Jaillon, P. Determination of acyclovir in plasma by solid-phase extraction and column liquid chromatography. Ther. Drug Monit. 1999, 21 (1), 129-133.
25. Boulieu, R.; Gallant, C.; Silberstein, N. Determination of acyclovir in human plasma by high-performance liquid chromatography. J. Chrom. B. 1997, 693, 233-236.
26. Qinn, R.P.; de Miranda, P.; Gerald, L.; Good, S.S. A Sensitive radioimmunoassay for the anti-viral agent BW 248U (9-(2-hydroxyethoxymethyl)guanine). Anal. Biochem. 1979, 98, 319.
27. Loregian, A.; Gatti, R.; Palu, G.; de Palo, E.F. Separation methods for acyclovir and related antiviral compounds. J. Chrom. B. 2001, 764, 289-311.
28. Eley, A.T. Pharmacokinetics of Phospholipid Formulations of AZT in the Pregnant Rat; The University of Georgia: Athens, 1999; Dissertation, 32-45, 60-81.
29. Peter, K.; Lalezari, J.P.; Gambertoglio, J.G. Quantification of zidovudine and individual zidovudine phosphates in preipheral blood mononuclear cells by a combined isocratic high performance liquid chromatography radioimmunoassay method. J. Pharmaceut. Biomed. Anal. 1996, 14 (4), 491-499.
30. Nadal, T; Ortuno, J.; Pascual, J.A. Rapid and sensitive determination of zidovudine and zidovudine glucuronide in human plasma by ion-pair high-performance liquid chromatography. J. Chrom. A 1996, 721 (1), 127-137.
31. Radwan, M.A. HPLC assay of theophylline and zidovudine in rat serum. J. Liq. Chrom. 1995, 18 (16), 3301-3309.
32. Almudaris, A.; Ashton, D.S.; Ray, A. Trace analysis of impurities in 3′-azido-3′-deoxythymidine by reversed-phase high-performance liquid-chromatography and thermospray mass-spectrometry. J. Chrom. A 1995, 689 (1), 31-38.
33. Radwan, M.A. Stability-indicating HPLC assay of zidovudine in extemporaneous syrup. Anal. Lett. 1994, 27 (6) 1159-1164.
34. Foldes, O.; Uherova, P.; Mayer, V. Plasma levels of the anti-HIV drug 3′-azido-2′,3′-dideoxythymidine (AZT)-determination by HPLC. Acta. Virol. 1993, 37 (2-3), 156-164.
35. Borvak, J.; Kasanick, J.; Mayer, V. HPLC-monitoring of AZT in HIV-infected patients plasma - A clinical study. Acta Virol. 1992, 36 (5), 428-434.
36. Sadrazadeh, S.M.H.; Ainardi, V.; Gordon, C. A Sensitive and rapid HPLC procedure for measuring zidovudine (AZT) in serum. Clin. Chem. 1989, 35 (6), 1181-1187.
37. Chen, Y.Q.; Bauman, J.G.; Chu, C.K. Practical synthesis of AZT and AZDU from xylose-efficient deoxygenation via nucleoside 2′-xanthates. Nucleos. Nucleoti. 1992, 11 (24), 693-705.